Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADME Study of Radiolabeled AZD0914 in Healthy Males
NCT02298920Phase 1Completed
- Sponsor
- Entasis Therapeutics
- Start
- Jan 2015
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of zoliflodacin in gonorrhea, sponsored by Entasis Therapeutics. Primary endpoints: Pharmacokinetic Parameters up to 11 days, Urine and Feces Pharmacokinetic Parameters up to 11 days and 1 more. Started Jan 2015; status: completed.
02
Drugs
zoliflodacin
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT02298920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02298920.